WallStreetZenWallStreetZen

NASDAQ: DNLI
Denali Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for DNLI

Based on 6 analysts offering 12 month price targets for Denali Therapeutics Inc.
Min Forecast
$28.00+65.39%
Avg Forecast
$44.83+164.81%
Max Forecast
$105.00+520.2%

Should I buy or sell DNLI stock?

Based on 6 analysts offering ratings for Denali Therapeutics Inc.
Strong Buy
Strong Buy
4 analysts 66.67%
Buy
2 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DNLI stock forecasts and price targets.

DNLI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-22
lockedlocked$00.00+00.00%2023-12-13
lockedlocked$00.00+00.00%2023-11-20
lockedlocked$00.00+00.00%2023-11-08
lockedlocked$00.00+00.00%2023-10-24
B. Riley Securities
Top 3%
98
Strong BuyInitiates Coverage On$38.00+124.45%2023-09-06

1 of 1

Forecast return on equity

Is DNLI forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.62%

Forecast return on assets

Is DNLI forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

DNLI revenue forecast

What is DNLI's revenue in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$190.1M-44.22%
Avg 2 year Forecast
$306.4M-10.1%
Avg 3 year Forecast
$280.4M-17.73%
DNLI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DNLI revenue growth forecast

How is DNLI forecast to perform vs Biotechnology companies and vs the US market?
Company
-3.02%
Industry
52.23%
Market
10%
DNLI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DNLI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DNLI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DNLI$16.93$44.83+164.81%Strong Buy
IBRX$3.50N/AN/A
CORT$22.45$36.00+60.36%Strong Buy
GLPG$36.24$44.00+21.41%Hold
MOR$17.62$11.29-35.93%Strong Buy

Denali Therapeutics Stock Forecast FAQ

Is Denali Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: DNLI) stock is to Strong Buy DNLI stock.

Out of 6 analysts, 4 (66.67%) are recommending DNLI as a Strong Buy, 2 (33.33%) are recommending DNLI as a Buy, 0 (0%) are recommending DNLI as a Hold, 0 (0%) are recommending DNLI as a Sell, and 0 (0%) are recommending DNLI as a Strong Sell.

If you're new to stock investing, here's how to buy Denali Therapeutics stock.

What is DNLI's revenue growth forecast for 2024-2026?

(NASDAQ: DNLI) Denali Therapeutics's forecast annual revenue growth rate of -3.02% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 52.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10%.

Denali Therapeutics's revenue in 2024 is $340,814,000.On average, 9 Wall Street analysts forecast DNLI's revenue for 2024 to be $26,274,122,939, with the lowest DNLI revenue forecast at $6,343,235,323, and the highest DNLI revenue forecast at $84,298,695,312. On average, 8 Wall Street analysts forecast DNLI's revenue for 2025 to be $42,341,717,668, with the lowest DNLI revenue forecast at $6,470,100,030, and the highest DNLI revenue forecast at $152,219,682,167.

In 2026, DNLI is forecast to generate $38,750,534,376 in revenue, with the lowest revenue forecast at $1,724,696,663 and the highest revenue forecast at $79,435,548,230.

What is DNLI's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: DNLI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is DNLI's Price Target?

According to 6 Wall Street analysts that have issued a 1 year DNLI price target, the average DNLI price target is $44.83, with the highest DNLI stock price forecast at $105.00 and the lowest DNLI stock price forecast at $28.00.

On average, Wall Street analysts predict that Denali Therapeutics's share price could reach $44.83 by Feb 22, 2025. The average Denali Therapeutics stock price prediction forecasts a potential upside of 164.81% from the current DNLI share price of $16.93.

What is DNLI's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: DNLI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.